0001127602-14-030037.txt : 20141017 0001127602-14-030037.hdr.sgml : 20141017 20141017162442 ACCESSION NUMBER: 0001127602-14-030037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141015 FILED AS OF DATE: 20141017 DATE AS OF CHANGE: 20141017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGER HARVEY J M D CENTRAL INDEX KEY: 0000932052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 141162129 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-10-15 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0000932052 BERGER HARVEY J M D C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 1 Chairman & CEO Common Stock 2014-10-15 4 P 0 12500 5.0982 A 1751786 I Ocean Capital Partners, Llc Common Stock 2014-10-16 4 P 0 12500 5.3854 A 1764286 I Ocean Capital Partners, Llc Common Stock 246054 I Daughter Common Stock 248745 I Daughter Common Stock 245251 I Wife Common Stock 1163564 D Shares were aquired pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote. The reporting person is a managing member of this LLC. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.34 to $5.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote. /s/Edward M. Fitzgerald, Attorney-in-Fact 2014-10-17